Harbin Honor Pharmaceutical Co., Ltd.
Securities Code: 002437 Securities Abbreviation: Honor Pharmaceutical Announcement No.: 2026-037
Announcement on the Listing and Circulation of Restricted Shares for the First Tranche of the 2024 Restricted Stock Incentive Plan Upon Expiration of the Second Vesting Period
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false representations, misleading statements, or material omissions.
Key Information Highlights:
- The conditions for lifting the second vesting period of the 2024 restricted stock incentive plan (first tranche) have been met by Harbin Honor Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"). A total of 92 eligible employees will have their restricted shares released, amounting to 14,267,400 shares, which is approximately 0.6398% of the Company's current total share capital.
- The listing and circulation date for the restricted shares to be released from restrictions is May 14, 2026.
On April 24, 2026, the Company held the Ninth Meeting of the Seventh Board of Directors, which approved the "Proposal on the Fulfillment of Conditions for the Second Vesting Period of the 2024 Restricted Stock Incentive Plan First Tranche." In accordance with the "Administrative Measures for Equity Incentives of Listed Companies," the "2024 Restricted Stock Incentive Plan (Draft)" (hereinafter referred to as the "Incentive Plan"), and the "2024 Restricted Stock Incentive Plan Performance Assessment and Management Measures" (hereinafter referred to as the "Assessment Measures"), the conditions for lifting the second vesting period of the first tranche of the Company's 2024 restricted stock incentive plan (hereinafter referred to as the "Incentive Plan") have been met. Based on the authorization granted by the Company's First Extraordinary General Meeting of Shareholders in 2024 to the Board of Directors, the Company has processed the lifting of restrictions on 14,267,400 restricted shares for 92 eligible employees. The relevant matters are hereby announced as follows:
I. Approval Procedures for the Incentive Plan